Related Experiment Video
Updated: Jun 20, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Inadequate mycophenolic acid exposure and acute rejection in kidney transplantation
A I Sánchez-Fructuoso1, M A M de la Higuera, M Giorgi
1Department of Nephrology, Hospital Clínico San Carlos, Madrid, Spain. sanchezfruct@telefonica.net
Introduction:
The clinical utility of predose levels of mycophenolic acid (MPA) monitoring among patients treated with mycophenolate mofetil (MMF) has been questioned. The aim of this study was to evaluate the impact of adequate MPA levels in the incidence of acute rejection episodes among a cohort of kidney transplant recipients.
Material And Methods:
In this retrospective study of 314 consecutive cases treated with tacrolimus, MMF, and steroids, evaluated 12-hour trough MPA samples during the first week as well as at 1, 3, 6, and 12 months as median values.
Results:
During the first week, the median values of MPA were 1.6 microg/mL (p25-75 0.7-2.7 microg/mL) on mean doses of 1.84 +/- 0.38 g/d. The incidence of acute rejection was 28%. The mean MPA levels during the first week were significantly lower among patients who developed rejection than in nonrejectors (1.5 +/- 0.1 vs 2.1 +/- 0.1 microg/mL; P < .001). There were no significant differences in trough tacrolimus levels between rejectors and nonrejectors (11.2 +/- 0.4 vs 11.6 +/- 1.2 microg/mL; P < .78). Logistic regression analysis showed that one of the predictive factors of acute rejection was a 12-hour trough MPA <1.6 microg/mL (relative risk [RR] 2.6; CI [confidence interval] 95% 1.6-4.3; P < .001).
Conclusions:
Adequate MPA exposure is important to prevent acute rejection. Taking into account that the routine measurement of the area under the curve of MPA is impractical, at least the follow-up of trough MPA levels may help in the management of renal transplant recipients.
Insights
Monitoring mycophenolic acid (MPA) levels in kidney transplant patients is crucial. Adequate MPA exposure, specifically trough levels, helps prevent acute rejection episodes after transplantation.
Area of Science:
- Nephrology
- Transplant Surgery
- Pharmacology
Background:
- Clinical utility of monitoring predose mycophenolic acid (MPA) levels in patients on mycophenolate mofetil (MMF) is debated.
- Acute rejection is a significant concern in kidney transplant recipients.
Purpose of the Study:
- To evaluate the impact of adequate MPA levels on acute rejection incidence.
- To assess the role of MPA trough levels in kidney transplant management.
Main Methods:
- Retrospective study of 314 kidney transplant recipients on tacrolimus, MMF, and steroids.
- Evaluated 12-hour trough MPA samples at various time points (first week, 1, 3, 6, 12 months).
Main Results:
- Incidence of acute rejection was 28%.
- Lower first-week MPA levels (<1.6 microg/mL) were significantly associated with acute rejection (RR 2.6).
- No significant difference in trough tacrolimus levels between rejectors and non-rejectors.
Conclusions:
- Adequate MPA exposure is vital for preventing acute rejection in kidney transplant recipients.
- Trough MPA level monitoring can aid in managing renal transplant patients, as routine AUC measurement is impractical.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Kidney Transplant I: Introduction
Acute Kidney Injury I: Introduction
Kidney Transplant III: Nursing Management